Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 30
Healthy volunteers: yes

Brief summary:
The objective of this study is to demonstrate that BI 10773 does not prolong the QT(c) interval more than placebo

Detailed description:

Arms:
arm 1: single oral (high and low) dose per subject arm 2: 2 single oral doses per subject arm 3: single oral dose per subject

Interventions: intervention 1: BI 10773 (low) intervention 2: Moxifloxacin intervention 3: BI 10773 Placebo intervention 4: BI 10773 (high)
Intervention descriptions: intervention 1: single oral dose intervention 2: single oral dose intervention 3: 2 times single dose intervention 4: single oral dose

Protocol document: